tirzepatide weight regain study Direct Link to JAMA Post Hoc Analysis of SURMOUNT-4: Cardiometabolic Parameter Change by on Withdrawal in Adults With Obesity : r/Zepbound Tirzepatide Demonstrates Sustained Weight Loss

Genetic Factors That Inform GLP-1 Suitability Certain genetic variants in GLP-1 receptor (GLP1R), GLP-1 insulin secretion (GIPR), and metabolism pathways (FTO, MC4R) may influence how your body responds to treatment

Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybjrg-Hansen A, et al

They are usually aggregated into sheets or alveolar groups and less commonly neurotropic or desmoplastic configurations are observed

Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy

Those who are obese and diabetic

this pathway has been recognized as critical to the reversal of diabetes and the recovery of impaired islet function after bariatric treatment 20,21,22